Barr Pharmaceuticals has announced that the company is in discussions with Ortho Women's Health & Urology, a division of Ortho-McNeil-Janssen Pharmaceuticals, concerning a definitive agreement to settle the outstanding patent litigation involving Ortho's oral contraceptive product, Ortho Tri-Cyclen LO.
Subscribe to our email newsletter
The US District Court of New Jersey has postponed the trial date. The general terms and status of the anticipated settlement will not be disclosed by either party until a definitive agreement is reached.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.